Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GPR55 cis regulatory suppressor of immune response RNA (GCSIR) is a human long non-coding RNA gene (lncRNA) located at cytogenetic region 2q37. It is also named Lnc-ITM2C-1. GCSIR is annotated as a non-protein-coding transcript, and available data do not identify it as a direct therapeutic target such as a receptor, enzyme, or transporter. Its function is inferred to be cis-acting regulatory control of immune response, possibly through modulation of GPR55 or immune-related pathways, but details are limited. No information is currently available about its involvement in major disease categories, as a biomarker, or as the target of specific drugs. Its role may be relevant in the context of viral infection, based on isolated findings linking similar lncRNAs to viral replication influence, but this is not confirmed for GCSIR specifically[1][2][3][4][5][6][8][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GPR55 cis regulatory suppressor of immune response RNA (GCSIR).